Exclusive | Meet the parents putting kids on Ozempic — and it’s dividing doctors: ‘Don’t fully understand long-term effects’

By the time he turned ten, Jenna Ceriani’s son was too heavy to play football. The local league kicked the budding ballplayer out after he tipped the scales at 155 pounds — well above their 125-pound cap. The middle schooler’s weight had become a safety liability for smaller players on the team, they explained. “Every time … Read more

Exclusive | Women are getting off-label Ozempic to treat a long-misunderstood health issue

Exclusive | Women are getting off-label Ozempic to treat a long-misunderstood health issue

At 16 years old, Megan Rappa was missing school for what felt like a full system breakdown. She’d suffered irregular and painful periods for years before a gynecologist finally named her condition — but still, nothing changed. “Even with a diagnosis, my symptoms were just mine to deal with and there was not a solution … Read more

Scientists discover ‘skinny gene’ variant that helps some lucky people stay lean

Scientists discover ‘skinny gene’ variant that helps some lucky people stay lean

Born thin? Slim chance. While some people agonize over tracking every calorie to maintain their figures, others seem to have won the genetic lottery with a naturally speedy metabolism — and all the health benefits that come with it. Now, scientists have found a specific “skinny gene” mutation that’s keeping about one in 7,000 people … Read more

Exclusive | On a GLP-1? There’s a vacation for that

Exclusive | On a GLP-1? There’s a vacation for that

Stamie Giallourakis was on her deathbed in early 2021 when she made herself a promise. At the time, she was over 200 pounds and hospitalized with severe COVID-19.  “I swore that if I survived — and I’m not being dramatic — I would try to once and for all be as healthy as I could … Read more

Some patients to score new super-effective ‘Triple G’ weight loss drug — before FDA approval

Some patients to score new super-effective ‘Triple G’ weight loss drug — before FDA approval

An unapproved weight loss drug is about to become available to more patients. Retatrutide — also known as “reta” — has been shown to produce dramatically greater weight loss than blockbuster drugs like Ozempic and Mounjaro. The experimental drug delivers a triple whammy by mimicking three hormones involved in appetite and metabolism: GLP-1, GIP and … Read more

‘Temporal wasting’: The GLP-1 side effect that makes patients ‘look suddenly older’

‘Temporal wasting’: The GLP-1 side effect that makes patients ‘look suddenly older’

Talk about losing face. By now, people are well aware of “Ozempic face,” the phenomenon in which people on GLP-1 medications notice saggy skin, sunken eyes and gaunt cheeks. Now, “temporal wasting” is the latest side effect that prematurely ages weight loss drug users, and has doctors concerned. Along with “Ozempic face,” another side effect … Read more

Which group achieves 41% more weight loss on GLP-1s like Mounjaro: study

Which group achieves 41% more weight loss on GLP-1s like Mounjaro: study

It’s a battle of the sexes. The diabetes-turned-weight-loss drug Mounjaro has been making headlines for its effectiveness at helping people shed pounds, even delivering better results than Ozempic. And when it comes to who loses more weight on the blockbuster drug, research has found one group comes out on top. It’s a battle of the … Read more

New studies reveal rare but real risk of GLP-1 drugs

New studies reveal rare but real risk of GLP-1 drugs

July 22 (Reuters) – The risk ‌of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 ​users were 37 percent higher than in … Read more

Weight loss drugs may improve job prospects and dating odds for one group

Weight loss drugs may improve job prospects and dating odds for one group

A recent study suggests GLP-1-related weight loss may improve some women’s relationships and employment status. Rebecca Diamond, professor of economics at Harvard University in Boston, independently published research that found an association between weight-loss medications and a change in women’s social and economic outcomes. Diamond used the Understanding America Study, a panel survey from the University of Southern California, … Read more

Ozempic nation: America’s GLP-1 use nearly quadruples in just two years

Ozempic nation: America’s GLP-1 use nearly quadruples in just two years

America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years. Now, the shift is showing up on the scale, with national obesity rates edging lower after years … Read more

Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders

Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders

Neurologists are warning that popular weight-loss medications could have severe negative effects on neurodegenerative conditions like ALS. Jinsy Andrews, MD, a neurologist and director of NYU Langone’s ALS Center, says the very mechanism that makes these drugs popular — rapid weight loss — can go against the biological needs of patients with neuromuscular disorders. GLP-1 agonists have shown … Read more

Woman develops ‘large, mucus-covered mass’ in her stomach after taking GLP-1 — how chugging diet cola cured it

Woman develops ‘large, mucus-covered mass’ in her stomach after taking GLP-1 — how chugging diet cola cured it

A woman went to the ER to deal with severe abdominal pain, nausea, and vomiting. She thought it might be due to stress. It turned out to be a goopy green mass that formed in her stomach — with a little help from her GLP-1. The 63-year-old was seen by doctors at Brigham and Women’s … Read more

Exclusive | Building staff in NYC’s richest zipcodes on guard after sharp rise in used needle stabbings — as GLP-1 craze rages on

Exclusive | Building staff in NYC’s richest zipcodes on guard after sharp rise in used needle stabbings — as GLP-1 craze rages on

There’s a nasty new job hazard to building employees in NYC’s most pampered zip codes — and it’s lurking in the trash. Residents at one luxe Upper East Side address received a sharp written warning after one staffer was shocked to discover they’d been jabbed by someone’s used needle while bagging building trash — and it wasn’t … Read more

The ‘longevity diet’ that can increase natural GLP-1 and reduce body fat: study

The ‘longevity diet’ that can increase natural GLP-1 and reduce body fat: study

The “fauxzempic” era is well underway. Many brands are marketing alternatives to GLP-1 weight-loss drugs, but certain foods may also boost the effects of the naturally occurring hormone responsible for reducing hunger and stabilizing blood sugar. A recent study found one diet that not only boosted GLP-1 but also increased longevity and reduced body fat. … Read more

Doctor shares the ‘most troubling trend’ in men’s health — and why biohacking is to blame

Doctor shares the ‘most troubling trend’ in men’s health — and why biohacking is to blame

Doctor’s orders: When it comes to longevity, DIY is a don’t. Peptides, GLP-1s and hormones have all become buzzy topics in the health and wellness world, with fans raving about personal transformations and biohacking wins. But just because you can buy something easily online doesn’t mean you should. In fact, doctors find the do-it-yourself mentality … Read more

How drugs like Ozempic are messing with people’s smell and taste

How drugs like Ozempic are messing with people’s smell and taste

GLP-1 meds could be stifling your senses. The drugs, originally developed to manage diabetes, have exploded in use after being approved to treat obesity, with as many as 1 in 8 adults currently taking the jab. But those lean-seeking masses could end up losing more than just their apple bottoms, as new research suggests the meds can … Read more

Will Ozempic get banned from the Olympics and World Cup?

Will Ozempic get banned from the Olympics and World Cup?

They’re sweeping the country — and raising questions in the locker room. At least one in eight American adults say they’ve used a GLP-1 drug such as Ozempic or Wegovy to lose weight or manage a chronic health condition, a stunning rise in just a few years. And while top athletes may seem unlikely candidates … Read more

GLP-1 users may be making a major weight-loss mistake, new study suggests

GLP-1 users may be making a major weight-loss mistake, new study suggests

Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity. In an Endocrine … Read more

Could drugs like Ozempic make people less violent — and even reduce crime?

Could drugs like Ozempic make people less violent — and even reduce crime?

Taking a shot at crime? GLP-1 medications like Ozempic and Mounjaro could be helping people make better choices — and not just with their food. A new study published today in the journal Criminology suggests these medications can actually make people less likely to act violently. Photographee.eu – stock.adobe.com Though GLP-1 agonists are prescribed to … Read more

Fashion retailers scrambling to sell $5B inventory as GLP-1 craze leads to plus-size surplus: report

Fashion retailers scrambling to sell B inventory as GLP-1 craze leads to plus-size surplus: report

Anti-fat jabs are throwing fashion a new curve.  A staggering $5 billion in clothing inventory is at risk of going to waste thanks to fashionistas melting away their waists on GLP-1 drugs, per alarming new reports.   As the A-list likes of singer Meghan Trainor and Sports Illustrated Swimsuit model Brooks Nader lead the charge in getting lean via Type 2 … Read more